产品名称
MISSION® esiRNA, targeting human FILIP1L
description
Powered by Eupheria Biotech
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
TGACCACAAATGCAAAGGAAACACATACCAAACTAGCCCTTGCTGAAGCCAGAGTTCAGGAGGAAGAGCAGAAGGCAACCAGACTAGAGAAGGAACTGCAAACGCAGACCACAAAGTTTCACCAAGACCAAGACACAATTATGGCGAAGCTCACCAATGAGGACAGTCAAAATCGCCAGCTTCAACAAAAGCTGGCAGCACTCAGCCGGCAGATTGATGAGTTAGAAGAGACAAACAGGTCTTTACGAAAAGCAGAAGAGGAGCTGCAAGATATAAAAGAAAAAATCAGTAAGGGAGAATATGGAAACGCTGGTATCATGGCTGAAGTGGAAGAGCTCAGGAAACGTGTGCTAGATATGGAAGGGAAAGATGAAGAGCTCATAAAAATGGAGGAGCAGTGCAG
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Quality Level
Gene Information
human ... FILIP1L(11259), FILIP1L(11259)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Mijung Kwon et al.
Oncotarget, 7(47), 77052-77070 (2016-10-25)
Filamin A interacting protein 1-like (FILIP1L) is an inhibitor of the canonical WNT pathway. WNT/β-catenin signaling and its downstream pathway, epithelial-to-mesenchymal transition (EMT), play a key role in ovarian cancer metastasis and chemoresistance. To study the clinical implications of FILIP1L
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持